FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry, and concerns a method for preparing a solid oral dosage form which contains a poorly soluble and/or poorly mouldable drug substance and a hydrophylic polymer. The method is implemented by using an extruder with an added unstable plasticiser in the form of a liquefied gas or a supercritical fluid, e.g. such as a supercritical carbon dioxide. The unstable plasticiser is added to accelerate material processing.
EFFECT: unstable plasticiser is used to reduce viscosity of the mould mixture, and/or improved solubility of the drug substance.
9 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING COMPOSITIONS BY EXTRUSION OF RESISTANT TO PRESSING PHARMACEUTICAL SUBSTANCES | 2006 |
|
RU2405539C2 |
METHOD FOR PREPARING SOLID DISPERSIONS OF HIGH CRYSTALLINE THERAPEUTIC COMPOUNDS | 2007 |
|
RU2454220C2 |
METHOD FOR MELT GRANULATION | 2009 |
|
RU2491918C2 |
PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
ANTI-RETROVIRAL COMBINATION | 2014 |
|
RU2675831C2 |
PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
ANTIRETROVIRAL COMBINATION | 2008 |
|
RU2531089C2 |
METHODS OF PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE CONTAINING PANCREATIN, AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE | 2015 |
|
RU2712142C2 |
DYNAMICALLY VULCANISED THERMOPLASTIC ELASTOMER FILM | 2011 |
|
RU2571737C2 |
PERORAL SOLID DOSAGE FORM WITH MYCOPHENOLIC ACID OR ITS SALT FOR USE AS AN IMMUNODEPRESSANT FOR TREATMENT OR PREVENTION OF ORGAN OR TISSUE TRANSPLANT REJECTION AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2670447C2 |
Authors
Dates
2011-10-10—Published
2006-11-07—Filed